{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:17:25Z","timestamp":1761218245313,"version":"3.37.3"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230033","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T17:34:46Z","timestamp":1583775286000},"page":"e0230033","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-9016","authenticated-orcid":true,"given":"Regina","family":"Michelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Tadmor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Aviv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galia","family":"Stemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan","family":"Majdob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lev","family":"Shvidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Shehadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masad","family":"Barhoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Braester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"pone.0230033.ref001","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"M Hallek","year":"2019","journal-title":"Am J Hematol"},{"key":"pone.0230033.ref002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.blre.2018.03.004","article-title":"Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections","volume":"32","author":"T Hilal","year":"2018","journal-title":"Blood Rev"},{"key":"pone.0230033.ref003","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrclinonc.2010.101","article-title":"Chemoimmunotherapy of chronic lymphocytic leukemia","volume":"7","author":"CS Tam","year":"2010","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"pone.0230033.ref004","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1182\/blood-2010-04-001230","article-title":"The clinical application of monoclonal antibodies in chronic lymphocytic leukemia","volume":"116","author":"SM Jaglowski","year":"2010","journal-title":"Blood"},{"key":"pone.0230033.ref005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3816\/CLML.2010.n.069","article-title":"Ofatumumab: a new CD20 monoclonal antibody therapy for B-cell chronic lymphocytic leukemia","volume":"10","author":"S O'Brien","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"pone.0230033.ref006","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12325-016-0451-1","article-title":"A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies","volume":"34","author":"K Tobinai","year":"2017","journal-title":"Adv Ther"},{"key":"pone.0230033.ref007","first-page":"1509","article-title":"The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives","volume":"10","author":"M Schlesinger","year":"1996","journal-title":"Leukemia"},{"key":"pone.0230033.ref008","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.4049\/jimmunol.1103693","article-title":"Exhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients","volume":"188","author":"FJ Beurskens","year":"2012","journal-title":"J Immunol"},{"key":"pone.0230033.ref009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/leu.2014.146","article-title":"Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL","volume":"29","author":"O Middleton","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"pone.0230033.ref010","doi-asserted-by":"crossref","first-page":"e0209024","DOI":"10.1371\/journal.pone.0209024","article-title":"A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity","volume":"14","author":"R Michelis","year":"2019","journal-title":"PLoS One"},{"key":"pone.0230033.ref011","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.4049\/jimmunol.1500087","article-title":"Structural basis for the function of complement component C4 within the classical and lectin pathways of complement","volume":"194","author":"S Mortensen","year":"2015","journal-title":"J. Immunol"},{"first-page":"2004","volume-title":"Chapter 6: Terminal Complement Complex: Regulation of Formation and Pathophysiological Functions.","author":"F Tedesco","key":"pone.0230033.ref012"},{"key":"pone.0230033.ref013","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.29438","article-title":"Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes","volume":"121","author":"SA Parikh","year":"2015","journal-title":"Cancer"},{"key":"pone.0230033.ref014","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.leukres.2017.02.011","article-title":"Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia","volume":"57","author":"FR Mauro","year":"2017","journal-title":"Leuk Res"},{"issue":"1","key":"pone.0230033.ref015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10428194.2012.706285","article-title":"Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia","volume":"54","author":"JA Freeman","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"pone.0230033.ref016","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"CA Diebolder","year":"2014","journal-title":"Science"},{"issue":"1","key":"pone.0230033.ref017","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pbio.1002344","article-title":"A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface","volume":"14","author":"RN de Jong","year":"2016","journal-title":"PLoS Biol"},{"key":"pone.0230033.ref018","first-page":"484","article-title":"Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation","volume":"73","author":"TE Mollnes","year":"1988","journal-title":"Clin. Exp. Immunol"},{"key":"pone.0230033.ref019","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/ndt\/gfh907","article-title":"Intravenous iron-gluconate during haemodialysis modifies plasma beta2-microglobulin properties and levels","volume":"20","author":"R Michelis","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"pone.0230033.ref020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000463030","article-title":"Patients with CLL and hypocomplementaemia have an impaired serum bactericidal activity against the Salmonella minnesota Re mutant","volume":"5","author":"L Varga","year":"1988","journal-title":"Complement"},{"key":"pone.0230033.ref021","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2249.1995.tb03480.x","article-title":"Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia","volume":"99","author":"L Varga","year":"1995","journal-title":"Clin. Exp. Immunol"},{"key":"pone.0230033.ref022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molimm.2015.01.028","article-title":"Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics","volume":"67","author":"JP Melis","year":"2015","journal-title":"Mol Immunol"},{"key":"pone.0230033.ref023","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0167-5699(86)90168-4","article-title":"Immunoglobulin flexibility in complement activation","volume":"7","author":"A Feinstein","year":"1986","journal-title":"Immunol Today"},{"key":"pone.0230033.ref024","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0161-5890(79)90010-5","article-title":"Reaction between the isolated globular sub-units of the complement component C1q and IgG-complexes","volume":"16","author":"NC Hughes-Jones","year":"1979","journal-title":"Mol. Immunol"},{"key":"pone.0230033.ref025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG Subclasses and Allotypes: From Structure to Effector Functions","volume":"5","author":"G Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"pone.0230033.ref026","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2567.1998.00472.x","article-title":"Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52","volume":"93","author":"S Redpath","year":"1998","journal-title":"Immunology"},{"key":"pone.0230033.ref027","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3324\/haematol.2010.036152","article-title":"Chronic lymphocytic leukemia and autoimmunity: a systematic review","volume":"96","author":"K Hodgson","year":"2011","journal-title":"Haematologica"},{"key":"pone.0230033.ref028","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"TJ Kipps","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"pone.0230033.ref029","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","article-title":"Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity","volume":"115","author":"M Herv\u00e9","year":"2005","journal-title":"J Clin Invest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T17:34:59Z","timestamp":1583775299000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230033"}},"subtitle":[],"editor":[{"given":"Spencer B.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230033","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,3,9]]}}}